Ram Sasisekharan

This inventor holds 73 USPTO granted patents and 29 published patent applications, plus 13 CIPO patents and 10 EPO patents, primarily in Antibody Engineering (CPC class C07K). Top assignees: Massachusetts Institute of Technology, Momenta Pharmaceuticals, Inc., Istituto Di Ricerche Chimiche E Biochimiche G Ronzoni. Active years: 1997-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ram Sasisekharan. Retrieved from https://idiyas.com/inventor/ram-sasisekharan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 73 (Patent Applications = 29)

% Patents Active = 72.6

CIPO Patents = 13 (Patent Applications = 9)

EPO Patents = 10 (Patent Applications = 18)

Average Co-Inventor Count = 4.6

ph-index = 24

Forward Citations = 1,171(Granted Patents)

Forward Citations (Not Self Cited) = 468(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Somerville, MA (US) (1997)
Lincoln, MA (US) (2005 - 2007)
Bedford, MA (US) (2005 - 2017)
Cambridge, MA (US) (2001 - 2022)
Lexington, MA (US) (2017 - 2022)

Company Filing History:

69 out of 8,578

Massachusetts Institute of Technology

patents

5 out of 121

Momenta Pharmaceuticals, Inc.

patents

2 out of 3

Istituto Di Ricerche Chimiche E Biochimiche G Ronzoni

patents

4. 2 out of 851

National University of Singapore

patents

5. 1 out of 1

Instituto Di Ricerche Chimiche E Biochimiche G. Ronzoni

patent

6. 1 out of 686

Northeastern University

patents

7. 1 out of 1,153

The Charles Stark Draper Laboratory, Inc.

patents

8. 1 out of 16,008

University of California

patents

9. 1 out of 1,627

University of Massachusetts

patents

10. 1 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 1997-2022

Loading Chart...

Areas of Expertise:

Bispecific Antibodies

Anti-Dengue Antibodies

Influenza Neutralization

Zika Virus

Ebola Glycoprotein

Polypeptide Agents

Hemagglutinin

Vaccine Development

Sulfated Polysaccharides

Chondroitinase ABC

Heparin Analysis

Carbohydrate Analysis

73 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11459405 - Bispecific antibodies having constant region mutations and uses therefor (2022-10-04),

2. 11421018 - Full spectrum anti-dengue antibody (2022-08-23),

3. 11267873 - Antibodies that bind zika virus envelope protein and uses thereof (2022-03-08),

4. 10947300 - Agents for influenza neutralization (2021-03-16),

5. 10894818 - Antibodies that bind Ebola glycoprotein and uses thereof (2021-01-19),

6. 10829545 - Antibodies that bind Zika virus envelope protein and uses thereof (2020-11-10),

7. 10538578 - Agents for influenza neutralization (2020-01-21),

8. 10526375 - Human Adaptation of H7 HA (2020-01-07),

9. 10519220 - Full spectrum anti-dengue antibody (2019-12-31),

10. 10301359 - Human adaptation of H3 influenza (2019-05-28),

11. 10226527 - Hemagglutinin polypeptides, and reagents and methods relating thereto (2019-03-12),

12. 9982037 - Agents for influenza neutralization (2018-05-29),

13. 9902764 - Full spectrum anti-dengue antibody (2018-02-27),

14. 9880167 - Anti-dengue virus antibodies and uses thereof (2018-01-30),

15. 9745352 - Influenza treatment and/or characterization, human-adapted HA polypeptides; vaccines (2017-08-29),

Title: The Innovative Journey of Inventor Ram Sasisekharan

Introduction: Ram Sasisekharan is a distinguished inventor based in Bedford, MA (US) known for his groundbreaking contributions to the field of biotechnology and pharmaceuticals.

Latest Patents: Ram Sasisekharan holds several patents in the areas of drug development, personalized medicine, and biopharmaceuticals, showcasing his continuous commitment to innovation.

Career Highlights: With a career spanning over three decades, Sasisekharan has held prominent positions in academia and industry, including serving as a Professor of Biological Engineering at MIT and as a co-founder of Momenta Pharmaceuticals, a biotechnology company focused on developing complex generic drugs.

Collaborations: Throughout his career, Ram Sasisekharan has collaborated with leading researchers, scientists, and pharmaceutical companies to advance the field of biotechnology, resulting in numerous successful projects and publications.

Conclusion: Ram Sasisekharan's relentless pursuit of innovation and his significant contributions to the biotechnology and pharmaceutical sectors have solidified his reputation as a visionary inventor shaping the future of healthcare and medicine.

Profile summary based on public USPTO records.